Description du projet
Combler le fossé en médecine reproductive
Alors que les taux de fécondité continuent de baisser et que la fécondation in vitro (FIV) connaît de faibles taux de réussite chez les couples plus âgés, le domaine de la médecine reproductive est confronté à des défis importants. En particulier, le fossé entre les secteurs universitaire et industriel dans les pays peu performants en matière de R&I, tels que la Grèce et l’Estonie, entrave les progrès, limitant les perspectives de carrière pour de nombreux spécialistes talentueux. Dans cette optique, le projet NESTOR, financé par l’UE, rassemblera des partenaires universitaires et industriels des Pays-Bas, de Grèce et d’Estonie, unis dans leur mission de faire progresser la recherche et l’innovation dans le domaine de la médecine reproductive. En mettant l’accent sur la médecine personnalisée, les techniques de fécondation in vitro et les tests prénataux non invasifs, NESTOR vise à donner à 23 talents de l’EER issus de pays peu performants en matière de R&I les moyens de développer leurs compétences, et à leur offrir de précieuses opportunités d’apprentissage tout au long de la vie.
Objectif
Constantly decreasing infertility rates and low success rates of in vitro fertilization (IVF) associated with the advanced age of couples create challenges in reproductive medicine. It is crucial to fill the existing gaps to unlock the socioeconomic benefits and boost the commercial viability of reproductive medicine in Europe. The gap in access to excellence is especially witnessed in Widening countries such as Greece and Estonia, where the academic sector is lagging behind, producing a low volume of commercialised innovations and low-quality clinical services. It poses obstacles in creating competitive positions for highly talented specialists with career perspectives and a strong interest in boosting local reproductive medicine, stimulating the brain drain, and minimizing life-long learning opportunities.
The contribution of the NESTOR project to solving these challenges is aimed at improving the research and innovation performance of institutions involved in reproductive medicine by boosting the collaboration between industry and academia in Widening and non-Widening countries through cross-sectoral and international mobilities. The NESTOR consortium consists of 8 partners from academic and industry partners from the Netherlands, Greece, and Estonia, ensuring the knowledge transfer and advancement in four key reproductive medicine modalities for the reproductively aged population: personalised medicine solutions, IVF embryo and uterine health studies, and novel non-invasive prenatal testing technologies.
In total, NESTOR will engage 23 ERA Talents from the Widening Countries, boosting their research skills, nurturing their innovative and entrepreneurial mindset, and providing them with other transferable skills. The well-tailored secondment methodology is aimed at raising their research profiles, improving their career perspectives and opportunities for life-long learning, which will help reverse the brain drain in the long term.
Mots‑clés
Programme(s)
Régime de financement
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinateur
51005 Tartu
Estonie